维普中文期刊产品整合服务
40篇 您的检索式:作者名="Ward Elizabeth"
    题名 作者 年代 出处 被引量
1Sodium glucose co-transporter 2 inhibition reduces succinate levels in diabetic mice显示文摘BACKGROUND Type 1 diabetes(T1D) is associated with major chronic microvascular complications which contribute significantly to diabetes associated morbidity.The protein primarily responsible for glucose reabsorption in the kidney is sodium glucose co-transporter 2(SGLT2). Presently, SGLT2 inhibitors are widely used in diabetic patients to improve blood glucose levels and prevent cardiovascular and renal complications. Given the broad therapeutic application of SGLT2 inhibitors, we hypothesised that SGLT2 inhibition may exert its protective effects via alterations of the gut microbiome and tested this in a type 1 diabetic mouse model of diabetic retinopathy.AIM To determine whether the treatment with two independent SGLT2 inhibitors affects gut health in a type 1 diabetic mouse model.METHODS The SGLT2 inhibitors empagliflozin or dapagliflozin(25 mg/kg/d) or vehicle dimethylsulfoxide(DMSO) were administered to C57 BL/6 J, Akita, Kimba and Akimba mice at 10 wk of age for 8 wk via their drinking water. Serum samples were collected and the concentration of succinate and the short chain fatty acid(SCFA) butyric acid was measured using gas chromatography-mass spectrometry. Enzyme-linked immunosorbent assay(ELISA) was performed to determine the concentration of insulin and leptin. Furthermore, the norepinephrine content in kidney tissue was determined using ELISA. Pancreatic tissue was collected and stained with haematoxylin and eosin and analysed using brightfield microscopy.RESULTS Due to the presence of the Akita allele, both Akita and Akimba mice showed a reduction in insulin production compared to C57 BL/6 J and Kimba mice.Furthermore, Akita mice also showed the presence of apoptotic bodies within the pancreatic islets. The acinar cells of Akita and Akimba mice showed swelling which is indicative of acute injury or pancreatitis. After 8 wk of SGLT2 inhibition with dapagliflozin, the intermediate metabolite of gut metabolism known as succinate was significantly reduced in Akimba mice when compared to DMSO treated mice. In addition, empagliflozin resulted in suppression of succinate levels in Akimba mice. The beneficial SCFA known as butyric acid was significantly increased in Akita mice after treatment with dapagliflozin when compared to vehicle treated mice. The norepinephrine content in the kidney was significantly reduced with both dapagliflozin and empagliflozin therapy in Akita mice and was significantly reduced in Akimba mice treated with empagliflozin.In non-diabetic C57 BL/6 J and Kimba mice, serum leptin levels were significantly reduced after dapagliflozin therapy.CONCLUSION The inhibition of SGLT2 reduces the intermediate metabolite succinate, increases SCFA butyric acid levels and reduces norepinephrine content in mouse models of T1 D. Collectively, these improvements may represent an important mechanism underlying the potential benefits of SGLT2 inhibition in T1 D and its complications.Lakshini Y Herat Natalie C Ward Aaron L Magno Elizabeth P Rakoczy Marcio G Kiuchi Markus P Schlaich Vance B Matthews 2020World Journal of Gastroenterology2020,26,23:3
2Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis显示文摘D.Keith George Stefano Goldwurm Graeme A. Macdonald Lex L. Cowley Neal I. Walker Patrick J. Ward Elizabeth C. Jazwinska Lawrie W. Powell 1998Gastroenterology1998,,2:2
3Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A‐RIPK1‐dependent necroptosis显示文摘Sahar A. Saddoughi Salih Gencer Yuri K. Peterson Katherine E. Ward Archana Mukhopadhyay Joshua Oaks Jacek Bielawski Zdzislaw M. Szulc Raquela J. Thomas Shanmugam P. Selvam Can E. Senkal Elizabeth Garrett‐Mayer Ryan M. De Palma Dzmitry Fedarovich Angen Liu 2012EMBO Mol Med2012,,1:2
4The investigation of enhanced bioremediation through the addition of macro and micro nutrients in a PAH contaminated soil显示文摘Liebeg Elizabeth Ward Cutright Teresa J 1999International Biodeterioration and Biodegradation1999,44,1:1
5The investigation of enhanced bioremediation through the addition of macro and micro nutrients in a PAH contaminated soil显示文摘Liebeg Elizabeth Ward Cutright Teresa J 1999International Biodete rioration and Biodegradation1999,44,1:1
6Cancer statistics, 2007 显示文摘Ahmedin Jemal Rebecca Siegel Elizabeth Ward 2007CA Cancer J Clin2007,57,:1
7A Global Profile of Germline Gene Expression in C. elegans显示文摘Valerie Reinke Harold E. Smith Jeremy Nance John Wang Carrie Van Doren Rebecca Begley Steven J.M. Jones Elizabeth B. Davis Stewart Scherer Samuel Ward Stuart K. Kim 2000Molecular Cell2000,,3:1
8International Variation in Prostate Cancer Incidence and Mortality Rates 显示文摘Melissa M. Center Ahmedin Jemal Joannie Lortet-Tieulent Elizabeth Ward Jacques Ferlay Otis Brawley Freddie Bray 2012European Urology2012,,:1
9Cancer Statistics 2010 显示文摘Ahmedin Jemal Rebecca Siegel Jiaquan Xu and Elizabeth Ward 2010CA Cancer J Clin2010,60,:1
10Cancer Statistics, 2009 显示文摘Ahmedin Jemal DVM Rebecca Siegel Elizabeth Ward 2009CA : A Cancer Journal for Cliniciarzs2009,55,4:1
11Cancer Statistics,2008显示文摘Ahmedin Jemal Rebecca Siegel Elizabeth Ward 2008CA Cancer J Clin2008,58,:1
12Cancer statistics,2009 显示文摘Ahmedin Jemal Rebecca Siegel Elizabeth Ward 2009CA Cancer J Clin2009,59,4:1
13Molecular cloning, expression and evaluation of phosphohydrolases for phytate-degrading activity显示文摘Elizabeth Moore Veronica R. Helly Orla M. Conneely Pauline P. Ward Ronan F. Power Denis R. Headon 1995Journal of Industrial Microbiology1995,,5:1
14Disparities in Receipt of Lymph Node Biopsy Among Early-Stage Female Breast Cancer Patients显示文摘Michael T. Halpern Amy Y. Chen Nicole S. Marlow Elizabeth Ward 2009Annals of Surgical Oncology2009,,3:1
15Childhood and adolescent cancer statistics, 2014显示文摘Elizabeth Ward Carol DeSantis Anthony Robbins Betsy Kohler Ahmedin Jemal 2014CA A Cancer Journal for Clinicians2014,,2:1
16Cancer Statistics, 2009 显示文摘Ahmedin Jemal Rebecca Siegel Elizabeth Ward 2009CA Cancer J Clin2009,59,4:1
17Cancer statistics, 2009显示文摘Ahmedin Jemal Rebecca Siegel Elizabeth Ward 2009CA Cancer J Clin2009,59,4:1
18Cancer statistics,2007显示文摘Ahmedin Jemal Rebecca Siegel Elizabeth ward 2007CA Cancer Joural of Clinical2007,57,1:1
19Cancer Sttistics显示文摘Jemal Ahmedin Murray Taylor Ward Elizabeth 2005CA Cancer J Lin2005,55,:1
20Cancer Statistics, 2007 显示文摘Ahmedin Jemal Rebecca Siegel Elizabeth Ward 2007CA Cancer Joural of Clinical2007,57,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费